Alnylam Pharmaceuticals
ALNY
#868
Rank
โ‚ฌ25.37 B
Marketcap
189,63ย โ‚ฌ
Share price
1.43%
Change (1 day)
-49.22%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company